Clinical Trial Update: IMVT-1402 in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Phase 2]

View source ↗

Summary

Phase 2 study of IMVT-1402 in adults with Chronic Inflammatory Demyelinating Polyneuropathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyneuropathy

Drugs mentioned

• IMVT-1402

Snippet

Sponsor: Immunovant Sciences GmbH | Conditions: Chronic Inflammatory Demyelinating Polyneuropathy | Phase 2 | Status: RECRUITING